More Business Wire
View Older Stories View Newer Stories-
bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells
-
Forrester Unveils Agendas For 2026 Technology & Innovation Forums In North America And EMEA
-
Exelixis Provides Update on the Phase 3 STELLAR-303 Trial Evaluating Zanzalintinib in Combination with an Immune Checkpoint Inhibitor in Patients with Metastatic Colorectal Cancer
-
Bed Bath & Beyond Launches Legendary Coupon Hunt
-
New labour market intelligence service for the bio-economy launched
-
HistoSonics Announces Financing with Participation from Yosemite Among Other Strategic Investors
-
VCARB Partners with Salesforce to Supercharge Fan Engagement with AI, Deploying Agentforce 360
-
Sable Offshore Corp. Enters Into Senior Secured Term Loan Amendment and Limited Waiver Under the PSA
-
Middleby Board of Directors Approves Spin-off of Midera Food Processing
-
AdvanCell Establishes U.S. Global Headquarters and Secures Flagship Manufacturing Facility in Greater Boston to Drive Growth Strategy
-
Print Creates an Enterprise Dark Data Problem. VasionⓇ Innovated Again to Find the Solution.
-
Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner
-
Radius Aerospace, an Arlington Capital Partners Portfolio Company, Appoints Aerospace and Defense Executive Tyler Evans as CEO
-
Scholar Rock to Showcase Neuromuscular Research Portfolio at 2026 Annual Cure SMA Research and Clinical Care Meeting and 2026 International Research Congress on FSHD
-
Brightstar Capital Partners Acquires Erdman, Expanding Its Architecture & Design Platform into Healthcare and Senior Living
-
BitGo Expands Institutional Access to DeFi Vault Strategies With Morpho
-
Applebee’s DOLLARITA® Returns This July
-
Littlejohn & Co. Promotes Charles Leung to Managing Director
-
Bayer and Iambic Collaborate to Advance Drug Discovery with AI
-
FEG Investment Advisors Marks Next Phase of Institutional Growth and Evolution
-
Jeff Man Joins Secure Ideas to Build PCI Practice and Expand Conference Presence
-
Element Care Receives $100,000 Grant from Cummings Foundation to Launch New Programs Targeting Senior Isolation and Community Connection
-
Fish & Richardson Introduces FishStream AI, a Proprietary Tool Supporting Strategic Patent Prosecution
-
Dennis Cornell Joins Evercore as Senior Managing Director in the Private Capital Markets Group
-
Cognito Therapeutics to Present New Data Highlighting Effects of Spectris™ on Lipid Transport Biomarkers in Alzheimer’s Disease at AAIC 2026
-
Cloudbreak Pharma Announces Results of First-of-Its-Kind Patient Survey on Pinguecula, Confirming Significant Unmet Need and Impact on Quality of Life
-
Centuri Announces More than $360 Million in Customer Awards
-
eGenesis Appoints Glenn S. Vraniak as Chief Financial Officer and Jennifer Bergheiser as Chief Commercial Officer
-
Wrangler® Celebrates Its Deep Roots in Country Music With Major Festival Activations Across the U.S. This Summer
-
Revvity Launches Signals AI, a Native Agentic Framework for Accelerating Scientific R&D
-
Spruce Biosciences Appoints Agnieszka Jurecka, M.D., Ph.D., MPH, as Vice President, Medical Affairs
-
Empower and the Employees Retirement System of Texas to Extend Long-Standing Partnership
-
Tenet to Report Its Second Quarter 2026 Results on July 24
-
Nordis Technologies President and COO Nicole Miller Authors Book on Authentic Leadership and Personal Growth
-
Marmon Industrial Energy & Infrastructure Expands VITALink® Portfolio with Launch of VITALink® MI Cable at NFPA Conference & Expo
-
Ambiq Announces Public Offering of Common Stock
-
Planning Events Just Got Easier: Navan Launches Unified Events Platform
-
Tutor Perini Announces Proposed Offering of $400 Million of Senior Notes Due 2033
-
BIOTECanada Opens Canada Pavilion at BIO 2026 Amid Major Policy Momentum for Canadian Biotech
-
Organon Completes Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device
-
Rayonier Advanced Materials Announces the Appointment of Daniel M. Krawczyk as Chief Executive Officer; Company Continues Comprehensive Review of Strategic Alternatives
-
AMC Theatres Enjoys Its Busiest Weekend of 2026 in the United States as Toy Story 5 Debuts With the Biggest Opening Weekend Box Office of the Year
-
GondolaBio Announces Positive Phase 2a Results Demonstrating 79% Plasma Protoporphyrin IX Reduction and Disease-Modifying Potential of PORT-77 for Erythropoietic Protoporphyria
-
ALTO Announces Full-Building Lease with DHL at ALTO Pinto 45
-
Nippon Sanso Matheson Announces Start of Production at Irwindale Air Separation Unit, Strengthening and Expanding Supply of Oxygen, Nitrogen, and Argon Across Southern California
-
Dealer Tire Financial, LLC Announces Offering of Senior Notes
-
Sinda Ltd. Announces Launch of its Initial Public Offering
-
British Crews Join Italy’s round‑the‑coast Marina Militare Nastro Rosa Tour 2026
-
Pacific Defense Launches Dual-Enclave 100G Ethernet Switch for Secure Multi-Mission C5ISR and Electronic Warfare Systems
-
The Winn-Dixie Company completes final Harveys Supermarket conversions, uniting stores under one iconic banner
